The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pharmacokinetic analysis program (multi) for microcomputer.
YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T., & UNO, T. (1981) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.4.879 · Cited by 2,450
The superfamily of organic anion transporting polypeptides
Hagenbuch, B., & Meier, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00633-8 · Cited by 861
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 641
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 522
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
Nishizato, Y. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00060-2 · Cited by 511
Kobayashi, D., Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051300 · Cited by 416
Shitara, Y., Itoh, T., Sato, H., Li, A. P., & Sugiyama, Y. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041921 · Cited by 340
Self-citationMolecular aspects of hepatobiliary transport
Muller, M., & Jansen, P. L. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1285 · Cited by 299
Sasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
Self-citationNakai, D., Nakagomi, R., Furuta, Y., Tokui, T., Abe, T., Ikeda, T., & Nishimura, K. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29609-9 · Cited by 217
Tamai, I., Nozawa, T., Koshida, M., Nezu, J.-I., Sai, Y., & Tsuji, A. (2001) · Pharmaceutical Research · doi:10.1023/a:1013077609227 · Cited by 211
Sugiyama, D., Kusuhara, H., Shitara, Y., Abe, T., Meier, P. J., Sekine, T., Endou, H., Suzuki, H., & Sugiyama, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29383-6 · Cited by 199
Self-citationBindingDB (2013) · PubMed · doi:10.7270/q2xw4m2t · Cited by 178
The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/Day
Davidson, M. H., Stein, E. A., Dujovne, C. A., Hunninghake, D. B., Weiss, S. R., Knopp, R. H., Illingworth, D. R., Mitchel, Y. B., Melino, M. R., Zupkis, R. V., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00742-4 · Cited by 167
Alcorn, J., Lu, X., Moscow, J. A., & McNamara, P. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038315 · Cited by 165
Ismair, M. G., Stieger, B., Cattori, V., Hagenbuch, B., Fried, M., Meier, P. J., & Kullak-Ublick, G. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.28704 · Cited by 156
Sinusoidal (Basolateral) Bile Salt Uptake Systems of Hepatocytes
Hagenbuch, B., & Meier, P. J. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007226 · Cited by 145
Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase Inhibitor
Kajinami, K., Takekoshi, N., & Saito, Y. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00116.x · Cited by 136 · cited 4×
“Pitavastatin is a highly potent inhibitor of 3-hydroxy-3methylglutaryl (HMG)-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis (Aoki et al., 1997; Kajinami et al., 2003).”
InfluentialUse of cDNA-Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug Interactions
Crespi, C. L., & Penman, B. W. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60205-7 · Cited by 129
Shitara, Y., Li, A. P., Kato, Y., Lu, C., Ito, K., Itoh, T., & Sugiyama, Y. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.33 · Cited by 116
Self-citationAoki, T., Nishimura, H., Nakagawa, S., Kojima, J., Suzuki, H., Tamaki, T., Wada, Y., Yokoo, N., Sato, F., KIMATA, H., et al. (1997) · PubMed · Cited by 104
Hasegawa, M., Kusuhara, H., Endou, H., & Sugiyama, Y. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046847 · Cited by 102
Self-citationRosuvastatin is a high affinity substrate of hepatic organic anion transporter OATP-C
Brown, C., Windass, A. S., Bleasby, K., & Lauffart, B. (2001) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)80225-7 · Cited by 60
Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver
Ismair, M. G. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00154-2 · Cited by 51
KIMATA, H., Fujino, H., Koide, T., Yamada, Y. M. A., Tsunenari, Y., & Yanagawa, Y. (1998) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.13.484 · Cited by 51
Interaction between Several Medicines and Statins
Fujino, H., Saito, T., Tsunenari, Y., & Kojima, J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1297087 · Cited by 20
Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs.
Kojima, J., OHSHIMA, T., Yoneda, M., & Sawada, H. (2001) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.16.497 · Cited by 14
Cited by
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citationImpact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Niemi, M., Pasanen, M. K., & Neuvonen, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002857 · Cited by 633
Metadata
- Authors
- Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 311
- Issue
- 1
- Pages
- 139-146
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2145804243
- Cited by
- 443
- References
- 31
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.